James Loerop - Net Worth and Insider Trading
James Loerop Net Worth
The estimated net worth of James Loerop is at least $113,964 dollars as of 2024-11-29. James Loerop is the Chief Business Officer of Aclaris Therapeutics Inc and owns about 21,688 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $82,848. James Loerop is also the EVP Business Development of Anika Therapeutics Inc and owns about 1,756 shares of Anika Therapeutics Inc (ANIK) stock worth over $31,116. Details can be seen in James Loerop's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Loerop has not made any transactions after 2023-08-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Loerop
James Loerop Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Loerop owns 2 companies in total, including Anika Therapeutics Inc (ANIK) , and Aclaris Therapeutics Inc (ACRS) .
Click here to see the complete history of James Loerop’s form 4 insider trades.
Insider Ownership Summary of James Loerop
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANIK | Anika Therapeutics Inc | 2020-07-09 | EVP Business Development |
| ACRS | Aclaris Therapeutics Inc | 2023-08-28 | Chief Business Officer |
James Loerop Latest Holdings Summary
James Loerop currently owns a total of 2 stocks. Among these stocks, James Loerop owns 21,688 shares of Aclaris Therapeutics Inc (ACRS) as of August 28, 2023, with a value of $82,848 and a weighting of 72.7%. James Loerop also owns 1,756 shares of Anika Therapeutics Inc (ANIK) as of July 9, 2020, with a value of $31,116 and a weighting of 27.3%.
Latest Holdings of James Loerop
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2023-08-28 | 21,688 | 3.82 | 82,848 |
| ANIK | Anika Therapeutics Inc | 2020-07-09 | 1,756 | 17.72 | 31,116 |
Holding Weightings of James Loerop
James Loerop Form 4 Trading Tracker
According to the SEC Form 4 filings, James Loerop has made a total of 2 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Aclaris Therapeutics Inc is the acquisition of 14,705 shares on August 28, 2023, which cost James Loerop around $99,994.
According to the SEC Form 4 filings, James Loerop has made a total of 1 transactions in Anika Therapeutics Inc (ANIK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Anika Therapeutics Inc is the sale of 1,244 shares on July 9, 2020, which brought James Loerop around $43,727.
Insider Trading History of James Loerop
- 1
James Loerop Trading Performance
GuruFocus tracks the stock performance after each of James Loerop's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Loerop is -86.51%. GuruFocus also compares James Loerop's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Loerop within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Loerop's insider trading performs compared to the benchmark.
Performance of James Loerop
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.58 | | | | | |
| Relative Return to S&P 500(%) | 5.59 | | | | | |
James Loerop Ownership Network
James Loerop Owned Company Details
What does Anika Therapeutics Inc do?
Who are the key executives at Anika Therapeutics Inc?
James Loerop is the EVP Business Development of Anika Therapeutics Inc. Other key executives at Anika Therapeutics Inc include SVP & Chief Operations Officer Anne Nunes , EVP & General Counsel & Corp Sec David Colleran , and EVP & CFO & Treasurer Michael L Levitz .
Anika Therapeutics Inc (ANIK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Anika Therapeutics Inc (ANIK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anika Therapeutics Inc (ANIK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Anika Therapeutics Inc (ANIK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Anika Therapeutics Inc Insider Transactions
James Loerop Mailing Address
Above is the net worth, insider trading, and ownership report for James Loerop. You might contact James Loerop via mailing address: C/o Aclaris Therapeutics, Inc., 640 Lee Road, Suite 200, Wayne Pa 19087.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
